Telomir Pharmaceuticals, Inc. (TELO)
0.88
+0.10
(+12.81%)
USD |
NASDAQ |
Nov 06, 10:37
Telomir Pharmaceuticals Total Liabilities (Quarterly) : 0.3324M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3324M |
| March 31, 2026 | 0.8273M |
| December 31, 2025 | 1.428M |
| September 30, 2025 | 0.4228M |
| June 30, 2025 | 0.3484M |
| March 31, 2025 | 0.6523M |
| December 31, 2024 | 0.681M |
| September 30, 2024 | 0.5999M |
| Date | Value |
|---|---|
| June 30, 2024 | 0.5342M |
| March 31, 2024 | 0.4866M |
| December 31, 2023 | 1.336M |
| September 30, 2023 | 3.140M |
| June 30, 2023 | 2.033M |
| March 31, 2023 | |
| December 31, 2022 | 0.986M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 115.90B |
| Eli Lilly & Co. | 107.80B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.366M |
| Shareholders Equity (Quarterly) | 5.034M |
| Debt to Equity Ratio | 0.0271 |
| Current Ratio | 16.14 |
| Net Debt Paydown Yield | -0.03% |